Animal Parasiticides Market Is Anticipated to Reach a Significant Valuation of US$ 13.6 Billion By 2032

The animal parasiticides market in the United States is a significant industry with a substantial market size. It caters to the demand for products used to control and treat parasitic infections in various animals, including pets and livestock. With a population of pets and a thriving livestock industry, the market for animal parasiticides in the United States is estimated to be worth billions of dollars annually. Animal parasiticides come in different forms, such as topical treatments, oral medications, collars, sprays, and dips. These products target a range of parasites, including fleas, ticks, mites, worms, and other external or internal pests. They provide protection and help prevent the harm caused by these parasites to animals' health and well-being.

The United States animal parasiticides market is highly competitive, with several major players in the industry. Companies like Zoetis, Merck Animal Health, Bayer Animal Health, Boehringer Ingelheim, Elanco Animal Health, and Ceva Animal Health are among the key manufacturers and distributors of animal parasiticides in the country.

𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗙𝗿𝗲𝗲 𝗦𝗮𝗺𝗽𝗹𝗲 𝗖𝗼𝗽𝘆 𝗼𝗳 𝘁𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁: https://www.factmr.com/connectus/sample?flag=S&rep_id=4316?PJ

The animal parasiticides market plays a vital role in veterinary care, addressing the challenge of parasitic infections that can impact the health of companion animals and livestock. Parasitic infestations not only pose a threat to animal health but also have implications for human health, making effective parasiticide solutions crucial in maintaining a healthy human-animal interface. The market encompasses a wide range of products, including anthelmintics, ectoparasiticides, and endoparasiticides, each designed to combat specific types of parasites. The increasing awareness of zoonotic diseases, coupled with the growing global pet and livestock populations, has driven the demand for innovative and effective animal parasiticides.

One of the primary drivers of the animal parasiticides market is the rising prevalence of parasitic infections in animals. As the global climate changes and human-animal interactions intensify, the risk of parasitic infestations has increased, necessitating a proactive approach to parasitic control. Additionally, the shift towards urbanization has led to a closer cohabitation of humans and animals, further emphasizing the need for robust parasiticides to prevent the transmission of diseases from animals to humans.

𝗞𝗲𝘆 𝗳𝗶𝗻𝗱𝗶𝗻𝗴𝘀 𝗼𝗳 𝘁𝗵𝗲 𝗔𝗻𝗶𝗺𝗮𝗹 𝗣𝗮𝗿𝗮𝘀𝗶𝘁𝗶𝗰𝗶𝗱𝗲𝘀 𝗺𝗮𝗿𝗸𝗲𝘁 𝘀𝘁𝘂𝗱𝘆:

The report provides a present market outlook on Animal Parasiticides. Additionally, the Animal Parasiticides market share is anticipated to grow with a CAGR of 6.6% in the forecast period.

Regional breakdown of the Animal Parasiticides market based on predefined taxonomy.

Innovative manufacturing processes implemented by Animal Parasiticides vendors in detail.

Region-wise and country-wise fragmentation of the Animal Parasiticides market to grasp the revenue, and growth outlook in these areas.

Changing preferences among consumers across various regions and countries.

Factors (Positive and Negative) impacting the growth of the global Animal Parasiticides market.

Animal Parasiticides price, market share, and Trends forecast for assessment period 2022-2032

𝗧𝗵𝗲 𝗲𝗰𝘁𝗼𝗽𝗮𝗿𝗮𝘀𝗶𝘁𝗲𝘀 𝘀𝗲𝗴𝗺𝗲𝗻𝘁 𝘄𝗶𝗹𝗹 𝗴𝗮𝗶𝗻 𝘁𝗵𝗲 𝗱𝗼𝗺𝗶𝗻𝗮𝗻𝘁 𝗺𝗮𝗿𝗸𝗲𝘁 𝘀𝗵𝗮𝗿𝗲

Ectoparasites, as a product category, had the highest market share of about 52% in 2021. Throughout the whole projected period, this market segment is anticipated to continue to dominate.

Ectoparasiticides are anticipated to account for more than half of the whole market for animal parasiticides over the projected period. The increase in external parasites like ticks, lice, mites, flies, and fleas, which feed on the blood of these animals and eventually human cells if swallowed, is likely what is driving the growth of this industry.

Ectoparasiticides are therefore becoming increasingly common in veterinary medicine. Additionally, substantial conferences are held by key ectoparasiticide companies to disseminate information on the several ectoparasiticides for cats, calves, and dogs that are limiting their growth. Research Research is being done to create effective anti-parasite compounds. Thus, ectoparasiticides are expected to grow at a 6.3% CAGR during 2022-2032.

𝗥𝗲𝗰𝗲𝗻𝘁 𝗗𝗲𝘃𝗹𝗼𝗽𝗺𝗲𝗻𝘁𝘀:

In February 2020, the FDA approved Simparica TrioTM, a brand-new combination canine parasite prevention medicine from Zoetis Inc. This medication, which comes in the shape of a monthly chewable, offers complete defence against ticks, heartworm infections, roundworms, and fleas. It was the first canine combination formula with isoxazoline ever produced in the nation.

Another market leader, Merck Animal Health, produces drugs for poultry, pigs, equines, aquaculture, and companion animals. Its products include ACTIVYL® for the avoidance of flea infestations, POSATEX® and MOMETAMAX® for the treatment of bacterial ear infections, and VETSULIN® for the control of diabetic mellitus in dogs and cats. The company won the animal farm award in January 2020 for their piglet immunisation programme for 2019. Piglets receiving the PORCILIS® Lawsonia vaccine are protected from the strain of bacteria lawsonia intracellularis that causes the intestinal ailment ileitis, was awarded for it.

𝗣𝗿𝗼𝗺𝗶𝗻𝗲𝗻𝘁 𝗣𝗹𝗮𝘆𝗲𝗿𝘀 𝗶𝗻 𝗧𝗵𝗲 𝗚𝗹𝗼𝗯𝗮𝗹 𝗠𝗮𝗿𝗸𝗲𝘁

Zoetis, Inc.,
Merck Animal Health,
Ceva Sante Animale,
Boehringer Ingelheim GmbH, and
Elanco Animal Health.

𝗞𝗲𝘆 𝗦𝗲𝗴𝗺𝗲𝗻𝘁𝘀 𝗖𝗼𝘃𝗲𝗿𝗲𝗱 𝗜𝗻 𝗧𝗵𝗲 𝗔𝗻𝗶𝗺𝗮𝗹 𝗣𝗮𝗿𝗮𝘀𝗶𝘁𝗶𝗰𝗶𝗱𝗲𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 𝗥𝗲𝗽𝗼𝗿𝘁

𝗕𝘆 𝗣𝗿𝗼𝗱𝘂𝗰𝘁 𝗧𝘆𝗽𝗲 :
Ectoparasiticides
Oral Tablets
Dips
Spray
Spot-on
Others
Endoparasiticides
Oral Suspension
Injectable
Feed Additives
Others
Endectocides

𝗕𝘆 𝗦𝗽𝗲𝗰𝗶𝗲𝘀 :
Food-Producing Animals
Cattle
Poultry
Swine
Others
Companion Animals
Dogs
Felines
Others
Other Livestock

𝗕𝘆 𝗥𝗲𝗴𝗶𝗼𝗻 :
North America
Europe
Asia Pacific (APAC)
Latin America
Middle East & Africa (MEA)

𝗞𝗲𝘆 𝗠𝗮𝗿𝗸𝗲𝘁 𝗧𝗿𝗲𝗻𝗱𝘀

Preventive Healthcare Focus: There is a noticeable trend in the animal parasiticides market towards preventive healthcare. Pet owners and livestock farmers are increasingly embracing the concept of regular parasite prevention rather than reactive treatment. This shift is driving the demand for prophylactic parasiticide products that offer long-lasting protection against a spectrum of parasites.

Advancements in Formulations: The market is experiencing advancements in parasiticide formulations, with a focus on improving efficacy, safety, and ease of administration. Innovative formulations, such as spot-on treatments, oral chews, and injectables, are gaining popularity for their convenience and ability to enhance compliance in both companion animals and livestock.

Focus on Zoonotic Disease Prevention: With an increasing awareness of zoonotic diseases, there is a growing emphasis on using animal parasiticides as a preventive measure to reduce the risk of disease transmission from animals to humans. This trend aligns with public health initiatives and underscores the interconnectedness of human and animal health.

Rise in Companion Animal Ownership: The growing trend of pet ownership, especially in urban areas, is a key driver for the animal parasiticides market. Pet owners are increasingly recognizing the importance of regular parasite control to ensure the well-being of their pets. This has led to a surge in demand for safe and effective parasiticides tailored for companion animals.

Integration of Technology: Technology integration is transforming the landscape of the animal parasiticides market. This includes the development of smart parasiticides, wearable devices for monitoring and controlling parasitic infections, and digital platforms for tracking and managing parasitic control programs. These technological innovations enhance precision and provide real-time data for effective parasite management.

𝗚𝗲𝘁 𝗖𝘂𝘀𝘁𝗼𝗺𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗼𝗻 𝘁𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁 𝗳𝗼𝗿 𝗦𝗽𝗲𝗰𝗶𝗳𝗶𝗰 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀:https://www.factmr.com/connectus/sample?flag=RC&rep_id=4316?PJ

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E Mail : sales@factmr.com

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories.

This release was published on openPR.